Ann Arbor-area start-up Tangent Medical Technologies received a key nod of approval from the Food and Drug Administration to start selling an alternative device to traditional intravenous (IV) drug delivery systems.

Tangent Medical Technologies co-founders (l-r) Adrienne Harris, Elyse Kemmerer and Steven White stand next to an injectable training arm with an IV system at their Packard Street office.

Tangent Medical Technologies, Inc., is a seed stage medical device development company formed in 2009 as a spinout from the University of Michigan’s Medical Innovation Center (MIC) fellowship program. Tangent was created to address health and safety shortcomings of existing catheter stabilization products for peripheral intravenous (PIV) fluid/medication delivery systems. Tangent’s patent-pending Novacath™ represents the next generation of stabilized catheter systems for fluid/medication delivery.

This page is a "seed"

This page about a business is a placeholder and may have little to no useful information. You can help Arborwiki by clicking the edit button and adding as much as you can. If you think this article has reached the point where it's grown beyond being a first start, please remove {{biz-stub}} from the article.